Liver transplantation for metabolic liver diseases.

[1]  C. Colombo.  Liver Disease in Cystic Fibrosis , 2006, Journal of pediatric gastroenterology and nutrition.

[2]  K. Reddy,et al.  Recurrence of Diseases Following Orthotopic Liver Transplantation , 2006, The American Journal of Gastroenterology.

[3]  M. Hodson,et al.  Variceal hemorrhage and cystic fibrosis: Outcomes and implications for liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  H. Bonkovsky,et al.  Liver transplantation for erythropoietic protoporphyria liver disease , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[5]  F. Rodrigues,et al.  Neonatal hemochromatosis — medical treatment vs. transplantation: The king's experience , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  A. Burlina,et al.  Liver and liver cell transplantation for glycogen storage disease type IA. , 2005, Acta gastro-enterologica Belgica.

[7]  N. Polissar,et al.  Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. , 2005, Gastroenterology.

[8]  R. Carithers,et al.  Practice Guidelines : Evaluation of the Patient for Liver Transplantation , 2005 .

[9]  B. Gridelli,et al.  Orthotopic liver transplantation for alagille syndrome. , 2005, Transplantation proceedings.

[10]  B. Gridelli,et al.  Orthotopic liver transplantation for Byler's disease. , 2005, Transplantation proceedings.

[11]  A. Battezzati,et al.  Effects of liver transplantation on the nutritional status of patients with cystic fibrosis * , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[12]  Steven R. Martin,et al.  Epidemiology of liver disease in cystic fibrosis: a longitudinal study. , 2004, Journal of hepatology.

[13]  D. Perlmutter.  Alpha-1-antitrypsin deficiency: diagnosis and treatment. , 2004, Clinics in liver disease.

[14]  D. Samuel,et al.  No hepatic iron overload 12 years after liver transplantation for hereditary hemochromatosis , 2004, Hepatology.

[15]  A. Freire,et al.  Familial amyloid polyneuropathy and liver transplantation. , 2004, Journal of hepatology.

[16]  N. Heaton,et al.  Successful pregnancy after combined renal–hepatic transplantation in glycogen storage disease type Ia , 2004, Journal of Inherited Metabolic Disease.

[17]  K. Kowdley,et al.  Targeted screening for hereditary haemochromatosis in high‐risk groups , 2004 .

[18]  P. Angus,et al.  Patient and graft survival after liver transplantation for hereditary hemochromatosis: Implications for pathogenesis , 2004, Hepatology.

[19]  K. Kowdley.  Liver transplantation: An “in vivo” model for the pathophysiology of hemochromatosis? , 2004, Hepatology.

[20]  A. Burke,et al.  Non‐Alcoholic Fatty Liver Disease, Non‐Alcoholic Steatohepatitis and Orthotopic Liver Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  B. Ericzon,et al.  Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry , 2004, Transplantation.

[22]  J. Hoofnagle,et al.  A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis , 2004, Hepatology.

[23]  M. A. al Shahed,et al.  Living related liver transplantation in 13 cases of progressive familial intrahepatic cholestasis. , 2003, Transplantation proceedings.

[24]  N. Weiss,et al.  Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. , 2003, Gastroenterology.

[25]  B. Neuschwander‐Tetri,et al.  Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone , 2003, Hepatology.

[26]  F. Schildberg,et al.  Treatment of Crigler-Najjar type 1 disease: relevance of early liver transplantation. , 2003, Journal of pediatric surgery.

[27]  James G Kench,et al.  Long‐term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C , 2003, Hepatology.

[28]  D. V. van Thiel,et al.  Liver transplantation for Wilson's disease. , 2003, Journal of hepatology.

[29]  G. Alexander,et al.  Long-term outcome of liver transplantation for familial hypercholesterolemia. , 2003, Transplantation proceedings.

[30]  A. Morabito,et al.  Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome , 2002, Hepatology.

[31]  R. N. Macsween,et al.  Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? , 2002, Journal of clinical pathology.

[32]  M. Berenguer,et al.  Contribution of obesity to hepatitis C-related fibrosis progression , 2002, American Journal of Gastroenterology.

[33]  J. Buckels,et al.  Transplantation for cystic fibrosis: Outcome following early liver transplantation , 2002, Journal of gastroenterology and hepatology.

[34]  R. Sokol,et al.  Cholangiocyte Biology and Cystic Fibrosis Liver Disease , 2001, Seminars in liver disease.

[35]  S. Thung,et al.  ORTHOTOPIC LIVER TRANSPLANTATION FOR WILSON’S DISEASE: A SINGLE-CENTER EXPERIENCE , 2001, Transplantation.

[36]  M. Caggana,et al.  Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. , 2001, Annals of human genetics.

[37]  J. Dixon,et al.  Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. , 2001, Gastroenterology.

[38]  K. Batts,et al.  Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[39]  R. Fisher,et al.  Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[40]  P. Thuluvath,et al.  Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: A case‐control study , 2000, Hepatology.

[41]  D. Cox,et al.  Copper-dependent trafficking of Wilson disease mutant ATP7B proteins. , 2000, Human molecular genetics.

[42]  S. Metral,et al.  The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. , 2000, Brain : a journal of neurology.

[43]  T. Therneau,et al.  Iron overload in cirrhosis—HFE genotypes and outcome after liver transplantation , 2000, Hepatology.

[44]  W. Irish,et al.  Liver transplantation for Wilson's disease: a single-center experience. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[45]  F. J. Farrell,et al.  Long-term follow-up after liver transplantation in patients with hepatic iron overload. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[46]  P. Friend,et al.  Biliary complications in liver transplantation for cystic fibrosis. , 1999, Transplantation proceedings.

[47]  S. Uemoto,et al.  Living related liver transplantation from heterozygote genetic carriers to children with Wilson’s disease , 1999, Pediatric transplantation.

[48]  S. Caldwell,et al.  Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease , 1999, Hepatology.

[49]  R. Perdigoto,et al.  Liver transplantation for familial amyloid polyneuropathy. , 1998, Hepato-gastroenterology.

[50]  H. Hefter,et al.  Cerebral manifestation of Wilson's disease successfully treated with liver transplantation , 1998, Neurology.

[51]  S. Lindstedt,et al.  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione) , 1998, Journal of Inherited Metabolic Disease.

[52]  P. Rosenthal,et al.  Liver transplantation for the treatment of urea cycle disorders , 1998, Journal of Inherited Metabolic Disease.

[53]  C. Sabin,et al.  Outcome of orthotopic liver transplantation in patients with haemophilia , 1998, Gut.

[54]  Jamieson Nv.  The results of combined liver/kidney transplantation for primary hyperoxaluria (PH1) 1984-1997. The European PH1 transplant registry report. European PH1 Transplantation Study Group. , 1998 .

[55]  P. Brissot,et al.  A reappraisal of hepatic siderosis in patients with end-stage cirrhosis: practical implications for the diagnosis of hemochromatosis. , 1997, The American journal of surgical pathology.

[56]  E. Furtado,et al.  Sequential liver transplantation. , 1997, Transplantation proceedings.

[57]  C. Lui,et al.  Neurological improvement of Wilson's disease after liver transplantation. , 1997, Transplantation proceedings.

[58]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[59]  P. Rosenthal,et al.  Current therapy for Crigler‐Najjar syndrome type 1: Report of a world registry , 1996, Hepatology.

[60]  J. Rank,et al.  Follow-up after liver transplantation for protoporphyric liver disease. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[61]  S. Hübscher,et al.  Transplantation for end stage liver disease related to alpha 1 antitrypsin. , 1996, Transplantation.

[62]  D. Häussinger,et al.  Long-term survival in patients with hereditary hemochromatosis. , 1996, Gastroenterology.

[63]  L. Powell.  Hemochromatosis: the impact of early diagnosis and therapy. , 1996, Gastroenterology.

[64]  D. Mack,et al.  Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis. , 1995, The Journal of pediatrics.

[65]  J. Emond,et al.  Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease). , 1995, Journal of pediatric surgery.

[66]  T. Sveger,et al.  The liver in adolescents with α‐antitrypsin deficiency , 1995 .

[67]  F. J. Farrell,et al.  Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. , 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[68]  P. Friend,et al.  Liver transplantation for hepatic cirrhosis in cystic fibrosis. , 1994, Archives of disease in childhood.

[69]  F. J. Farrell,et al.  Outcome of liver transplantation in patients with hemochromatosis , 1994, Hepatology.

[70]  C. Colombo,et al.  Hepatobiliary Disease in Cystic Fibrosis , 1994, Seminars in liver disease.

[71]  F. Collins,et al.  Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. , 1993, Gastroenterology.

[72]  J. Rommens,et al.  The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene , 1993, Nature Genetics.

[73]  A. Mason,et al.  Intractable neurological Wilson's disease treated with orthotopic liver transplantation , 1993, Digestive Diseases and Sciences.

[74]  H. Krakauer,et al.  AN ANALYSIS OF LIVER TRANSPLANT EXPERIENCE FROM 37 TRANSPLANT CENTERS AS REPORTED TO MEDICARE , 1993, Transplantation.

[75]  J. Navarro,et al.  Liver cirrhosis in cystic fibrosis--therapeutic implications and long term follow up. , 1993, Archives of disease in childhood.

[76]  G. Jacobs,et al.  Orthotopic Liver Transplantation in Two Adults with Niemann‐Pick and Gaucher's Diseases: Implications for the Treatment of Inherited Metabolic Disease , 1993, Hepatology.

[77]  A. Khaghani,et al.  Normal levels of lipoproteins including lipoprotein(a) after liver-heart transplantation in a patient with homozygous familial hypercholesterolaemia. , 1992, The Quarterly journal of medicine.

[78]  M. Adham,et al.  ORTHOTOPIC LIVER TRANSPLANTATION FOR TYPE 1 GAUCHER'S DISEASE , 1992, Transplantation.

[79]  R. Williamson,et al.  Genotype analysis for ΔF508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease , 1992 .

[80]  B. Cesana,et al.  Surival and prognostic factors in 212 Italian patients with genetic hemochromatosis , 1992, Hepatology.

[81]  T. Starzl,et al.  Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome) , 1992, Transplant international : official journal of the European Society for Organ Transplantation.

[82]  T. Starzl,et al.  Liver transplantation for type IV glycogen storage disease. , 1991, The New England journal of medicine.

[83]  C. Gross,et al.  Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators. , 1990, The Journal of pediatrics.

[84]  I. Wanless,et al.  Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors , 1990, Hepatology.

[85]  D. Danks,et al.  Wilson's disease in adults with cirrhosis but no neurological abnormalities. , 1990, BMJ.

[86]  R. Busuttil,et al.  Orthotopic liver transplantation in the treatment of complications of type 1 Gaucher disease. , 1990, Transplantation.

[87]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[88]  E. Silverman,et al.  Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening. , 1989, The American review of respiratory disease.

[89]  C. Maurage,et al.  Meconium ileus and its equivalent as a risk factor for the development of cirrhosis: an autopsy study in cystic fibrosis. , 1989, Journal of pediatric gastroenterology and nutrition.

[90]  M. Doss,et al.  Hepatobiliary implications and complications in protoporphyria, a 20-year study. , 1989, Clinical biochemistry.

[91]  C. Herfarth,et al.  Hepatic transplantation in galactosemia. , 1989, Transplantation.

[92]  G. Holmgren,et al.  Homozygosity for the transthyretin‐met30‐gene in two Swedish sibs with familial amyloidotic polyneuropathy , 1988, Clinical genetics.

[93]  T. Starzl,et al.  Orthotopic liver transplantation for alpha-1-antitrypsin deficiency: an experience in 29 children and ten adults. , 1987, Transplantation proceedings.

[94]  J. Carlson,et al.  Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. , 1986, The New England journal of medicine.

[95]  F. Ruddle,et al.  Regional location of α1-antichymotrypsin and α1-antitrypsin genes on human chromosome 14 , 1986 .

[96]  H. Greene,et al.  α1-Antitrypsin deficiency presenting with ascites and cirrhosis in the neonatal period , 1983 .

[97]  T Sveger,et al.  Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants. , 1976, The New England journal of medicine.

[98]  R. Wright,et al.  Alpha-1-antitrypsin deficiency and liver in adults. , 1976, The Quarterly journal of medicine.

[99]  T. Starzl,et al.  Liver transplantation for type I and type IV glycogen storage disease , 2005, European Journal of Pediatrics.

[100]  K. Lindor,et al.  104 Time course of fibrosis progression in patients with nonalcoholic fatty liver disease , 2003 .

[101]  T. Starzl,et al.  Liver transplantation for glycogen storage disease types I, III, and IV , 1999, European Journal of Pediatrics.

[102]  J. Buckels,et al.  Indications and outcome of liver transplantation in tyrosinaemia type 1 , 1999, European Journal of Pediatrics.

[103]  P. Hedera,et al.  Diagnosis and treatment of Wilson's disease. , 1999, Seminars in neurology.

[104]  J. Hoofnagle,et al.  Molecular medicine and hemochromatosis: at the crossroads. , 1999, Gastroenterology.

[105]  P. Friend,et al.  Liver transplantation for hepatic cirrhosis in cystic fibrosis. , 1996, Journal of the Royal Society of Medicine.

[106]  D. Loulmet,et al.  Combined heart-lung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children , 1996 .

[107]  D. Perlmutter,et al.  Clinical manifestations of alpha 1-antitrypsin deficiency. , 1995, Gastroenterology clinics of North America.

[108]  D. Houssin,et al.  Liver transplantation for end-stage liver disease associated with alpha-1-antitrypsin deficiency in children: pretransplant natural history, timing and results of transplantation. , 1994, Journal of hepatology.

[109]  K. Detre,et al.  Liver transplantation in the United States: results from the National Pitt-UNOS Liver Transplant Registry. United Network for Organ Sharing. , 1994, Clinical transplants.

[110]  I. Sternlieb.  Wilson's Disease: Indications for Liver Transplants , 1984, Hepatology.

[111]  D. Cox,et al.  Liver disease associated with alpha1-antitrypsin deficiency in childhood. , 1976, The Journal of pediatrics.